Cargando…

Kynurenine 3-Monooxygenase Interacts with Huntingtin at the Outer Mitochondrial Membrane

The flavoprotein kynurenine 3-monooxygenase (KMO) is localised to the outer mitochondrial membrane and catalyses the synthesis of 3-hydroxykynurenine from L-kynurenine, a key step in the kynurenine pathway (KP) of tryptophan degradation. Perturbation of KP metabolism due to inflammation has long bee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Swaih, Aisha M., Breda, Carlo, Sathyasaikumar, Korrapati V., Allcock, Natalie, Collier, Mary E. W., Mason, Robert P., Feasby, Adam, Herrera, Federico, Outeiro, Tiago F., Schwarcz, Robert, Repici, Mariaelena, Giorgini, Flaviano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496550/ https://www.ncbi.nlm.nih.gov/pubmed/36140394 http://dx.doi.org/10.3390/biomedicines10092294

Ejemplares similares

A novel role for kynurenine 3-monooxygenase in mitochondrial dynamics
por: Maddison, Daniel C., et al.
Publicado: (2020)

Cellular Localization of Kynurenine 3-Monooxygenase in the Brain: Challenging the Dogma
por: Sathyasaikumar, Korrapati V., et al.
Publicado: (2022)

Structural basis of kynurenine 3-monooxygenase inhibition
por: Amaral, Marta, et al.
Publicado: (2013)

Inflammation control and improvement of cognitive function in COVID-19 infections: is there a role for kynurenine 3-monooxygenase inhibition?
por: Collier, Mary EW, et al.
Publicado: (2021)

A brain-permeable inhibitor of the neurodegenerative disease target kynurenine 3-monooxygenase prevents accumulation of neurotoxic metabolites
por: Zhang, Shaowei, et al.
Publicado: (2019)

Copy-number variation of the neuronal glucose transporter gene SLC2A3 and age of onset in Huntington's disease
por: Vittori, Angelica, et al.
Publicado: (2014)

Parkinson’s disease-associated mutations in DJ-1 modulate its dimerization in living cells
por: Repici, Mariaelena, et al.
Publicado: (2012)

DJ-1 in Parkinson’s Disease: Clinical Insights and Therapeutic Perspectives
por: Repici, Mariaelena, et al.
Publicado: (2019)

Aggregation-Prone Proteins Modulate Huntingtin Inclusion Body Formation in Yeast
por: Kantcheva, Ralitsa B., et al.
Publicado: (2014)

Functional Gene Expression Profiling in Yeast Implicates Translational Dysfunction in Mutant Huntingtin Toxicity
por: Tauber, Eran, et al.
Publicado: (2011)

The Kynurenine Pathway and Kynurenine 3-Monooxygenase Inhibitors
por: Hughes, Tamera D., et al.
Publicado: (2022)

Ablation of kynurenine 3-monooxygenase rescues plasma inflammatory cytokine levels in the R6/2 mouse model of Huntington’s disease
por: Bondulich, Marie Katrin, et al.
Publicado: (2021)

Tryptophan Challenge in Healthy Controls and People with Schizophrenia: Acute Effects on Plasma Levels of Kynurenine, Kynurenic Acid and 5-Hydroxyindoleacetic Acid
por: Sathyasaikumar, Korrapati V., et al.
Publicado: (2022)

Modulation of Enzyme Activity in the Kynurenine Pathway by Kynurenine Monooxygenase Inhibition
por: Phillips, Robert S., et al.
Publicado: (2019)

Esculetin Provides Neuroprotection against Mutant Huntingtin-Induced Toxicity in Huntington’s Disease Models
por: Pruccoli, Letizia, et al.
Publicado: (2021)

Kynurenine 3-Monooxygenase: An Influential Mediator of Neuropathology
por: Parrott, Jennifer M., et al.
Publicado: (2015)

Kynurenine Monooxygenase Expression and Activity in Human Astrocytomas
por: Vázquez Cervantes, Gustavo Ignacio, et al.
Publicado: (2021)

Significance of Kynurenine 3-Monooxygenase Expression in Colorectal Cancer
por: Liu, Chun-Yu, et al.
Publicado: (2021)

The Parkinson’s Disease-Linked Protein DJ-1 Associates with Cytoplasmic mRNP Granules During Stress and Neurodegeneration
por: Repici, Mariaelena, et al.
Publicado: (2018)

Therapeutic Targeting of Rab GTPases: Relevance for Alzheimer’s Disease
por: Jordan, Kate L., et al.
Publicado: (2022)

Rab11 modulates α-synuclein-mediated defects in synaptic transmission and behaviour
por: Breda, Carlo, et al.
Publicado: (2015)

Visualization of cell-to-cell transmission of mutant huntingtin oligomers
por: Herrera, Federico, et al.
Publicado: (2011)

Bacterial expression of human kynurenine 3-monooxygenase: Solubility, activity, purification()
por: Wilson, K., et al.
Publicado: (2014)

Kynurenine‐3‐monooxygenase: A new direction for the treatment in different diseases
por: Lu, Yifei, et al.
Publicado: (2020)

Kynurenine 3-monooxygenase is a critical regulator of renal ischemia–reperfusion injury
por: Zheng, Xiaozhong, et al.
Publicado: (2019)

Blockade of KAT II Facilitates LTP in Kynurenine 3-Monooxygenase Depleted Mice
por: Imbeault, Sophie, et al.
Publicado: (2021)

Full-length in meso structure and mechanism of rat kynurenine 3-monooxygenase inhibition
por: Mimasu, Shinya, et al.
Publicado: (2021)

Glycation potentiates neurodegeneration in models of Huntington’s disease
por: Vicente Miranda, Hugo, et al.
Publicado: (2016)

Diclofenac Identified as a Kynurenine 3-Monooxygenase Binder and Inhibitor by Molecular Similarity Techniques
por: Shave, Steven, et al.
Publicado: (2018)

Structural and mechanistic basis of differentiated inhibitors of the acute pancreatitis target kynurenine-3-monooxygenase
por: Hutchinson, Jonathan P., et al.
Publicado: (2017)

Protective Role of Kynurenine 3-Monooxygenase in Allograft Rejection and Tubular Injury in Kidney Transplantation
por: Lassiter, Randi, et al.
Publicado: (2021)

RAB39B is redistributed in dementia with Lewy bodies and is sequestered within aβ plaques and Lewy bodies
por: Koss, David J., et al.
Publicado: (2020)

Prognostic significance of kynurenine 3-monooxygenase and effects on proliferation, migration, and invasion of human hepatocellular carcinoma
por: Jin, Haojie, et al.
Publicado: (2015)

Kynurenine–3–monooxygenase inhibition prevents multiple organ failure in rodent models of acute pancreatitis
por: Mole, Damian J, et al.
Publicado: (2016)

Viability of diffuse large B-cell lymphoma cells is regulated by kynurenine 3-monooxygenase activity
por: Morita, Nanaka, et al.
Publicado: (2021)

Surface Expression of Kynurenine 3-Monooxygenase Promotes Proliferation and Metastasis in Triple-Negative Breast Cancers
por: Lai, Min-Hua, et al.
Publicado: (2021)

Protocatechuic acid prevents isoproterenol‐induced heart failure in mice by downregulating kynurenine‐3‐monooxygenase
por: Bai, Liyan, et al.
Publicado: (2023)

Kynurenine pathway metabolites in cerebrospinal fluid and blood as potential biomarkers in Huntington's disease
por: Rodrigues, Filipe B., et al.
Publicado: (2021)

Connectivity mapping uncovers small molecules that modulate neurodegeneration in Huntington’s disease models
por: Smalley, Joshua L., et al.
Publicado: (2015)

Pharmacological Inhibition of Indoleamine 2,3-Dioxygenase-2 and Kynurenine 3-Monooxygenase, Enzymes of the Kynurenine Pathway, Significantly Diminishes Neuropathic Pain in a Rat Model
por: Rojewska, Ewelina, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_modjvcobi6rrf1st7astuissa2